Loading...
ImmuniWeb® Discovery is a commercial external attack surface management tool by ImmuniWeb. QuimeraX External Attack Surface Management is a commercial external attack surface management tool by QuimeraX. Compare features, ratings, integrations, and community reviews side by side to find the best external attack surface management fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Mid-market and enterprise security teams managing sprawling attack surfaces across cloud, SaaS, and third-party integrations should prioritize ImmuniWeb® Discovery for its dark web monitoring and supplier risk visibility, capabilities most competitors either skip or bolt on as afterthoughts. The platform covers five NIST CSF 2.0 functions including asset discovery, continuous monitoring, and supply chain risk, which means it actually closes gaps in how you map external exposure rather than just flagging what you already know exists. Skip this if your organization needs deep cloud-native workload scanning or has zero tolerance for monitoring capabilities that lean detection over remediation; ImmuniWeb® Discovery is built for visibility-first teams, not for shops that demand integrated response automation.
QuimeraX External Attack Surface Management
Mid-market and enterprise security teams drowning in shadow infrastructure will get immediate value from QuimeraX External Attack Surface Management because it actually finds what you don't know you're exposing, not just rescans what's already in your inventory. The platform covers ID.AM and DE.CM across the NIST CSF 2.0 stack, meaning it identifies forgotten assets and keeps watching them without manual effort. Skip this if your organization has fewer than 50 employees or lacks the security operations maturity to act on continuous monitoring alerts; a small team will struggle to keep pace with the discovery volume QuimeraX surfaces.
ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web.
EASM platform for continuous monitoring of internet-exposed assets & vulnerabilities
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing ImmuniWeb® Discovery vs QuimeraX External Attack Surface Management for your external attack surface management needs.
ImmuniWeb® Discovery: ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web. built by ImmuniWeb. headquartered in Switzerland. Core capabilities include Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring..
QuimeraX External Attack Surface Management: EASM platform for continuous monitoring of internet-exposed assets & vulnerabilities. built by QuimeraX. headquartered in Mexico. Core capabilities include Automated external asset discovery and continuous monitoring, Subdomain and infrastructure identification, SSL/TLS certificate monitoring..
Both serve the External Attack Surface Management market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox